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Abstract
Tumours located within the brainstem comprise approximately a tenth of all paediatric brain tumours. Surgical biopsy of 
these tumours is technically challenging and has historically been associated with considerable risk. To this end, robot-
assisted surgery theoretically allows for increased accuracy and precision. In this study we report our experience using the 
Neuromate robot (Renishaw, Gloucestershire, UK) to perform robot-assisted stereotactic biopsy in children with tumours 
located within the brainstem. An uncontrolled prospective cohort study was performed (phase II) according to the IDEAL 
model for safe surgical innovation. All cases were recorded on a prospectively maintained database. The database was 
searched over a 2-year period between the 1st December 2015 and the 31st November 2017 to identify all children with 
brainstem tumours that underwent robot-assisted stereotactic brain biopsy. When accessible, the post-operative MRI scans 
and pre-operative plans were compared to assess the target point localisation error (TPLE). Adverse events were recorded 
prospectively according to whether they resulted in increased hospital stay, caused neurological injury, or lead to death. In 
all, 11 consecutive children were identified with brain tumours located within the brainstem. In 10/11 cases specimens were 
diagnostic; in the remaining case a further biopsy was successful. The most frequent pathology was DIPG (7/15). Seven 
patients underwent an early post-operative volumetric MRI; the calculated median TPLE was 2.7 mm (range 0.5–4.2 mm). 
There were no surgical complications noted. Robot-assisted stereotactic biopsy in children appears to be feasible and safe. 
Research databases and comparative studies are warranted to further assess the technique.
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Introduction
Tumours located within the brainstem comprise approxi-
mately a tenth of all paediatric brain tumours [1]. The most 
common of these tumours is diffuse intrinsic pontine glioma 
(DIPG). As DIPG is associated with a characteristic MRI 
appearance and can be diagnosed from imaging alone, it has 
been argued that brainstem biopsy is not warranted in most 
cases [2]. In addition, the majority of children with DIPG 
die within 2 years of diagnosis, and information obtained 
from biopsy has, up to now, not altered treatment strategy 
[3]. However, recent studies have suggested that molecu-
lar markers may aid prognostication [4]. Several clinical 
trials that utilise these molecular markers to personalise 
treatment regimens are now underway. The BIOMEDE 
trial (NCT02233049), for example, specifically randomises 
treatment to targets identified on biopsy, and importantly 
withholds treatment to targets that are not identified. A pre-
requisite to the enrolment of patients into such clinical trials 
is the acquisition of brain tumour tissue.
Surgical biopsy of brainstem tumours is technically chal-
lenging and has historically been associated with consider-
able risk [2]. Stereotactic brain biopsy is generally preferred 
to open biopsy unless an exophytic tumour component is 
identified. The most common trajectories are transcortical 
(transfrontal) via the cerebral peduncle and transcerebellar 
via the middle cerebellar peduncle; the former requires a 
longer trajectory and carries a risk of injury to the ventricles, 
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while the latter is performed prone and necessitates dis-
section of the nuchal musculature that is associated with 
increased pain. Whichever approach is selected, high accu-
racy and precision is mandated; if these requirements are 
met, a number of publications have demonstrated that the 
risks of brainstem tumour biopsy are potentially low [5–7].
Robot-assisted surgery theoretically allows for increased 
accuracy and precision. The first report of a robot-assisted 
stereotactic brain biopsy was in 1985 when a modified 
PUMA industrial robot (Advance Research and Robotics, 
CT, USA) was used to define the trajectory [8]. Although 
several subsequent studies have concluded that robot-
assisted stereotactic brain biopsy is feasible and safe [8–13], 
few have focused on children with brainstem pathology, who 
represent a unique patient group.
In this study, we report our experience using the Neu-
romate robot (Renishaw, Gloucestershire, UK) to perform 
robot-assisted stereotactic biopsy in children with tumours 
located within the brainstem.
Methods
The study was registered as a Service Evaluation study with 
the Great Ormond Street Hospital for Children NHS Foun-
dation Trust Clinical Audit Committee (#2237). Informed 
consent was not sought, as this was a Service Evaluation 
study.
An uncontrolled prospective cohort study was performed 
(phase II) according to the IDEAL model for safe surgical 
innovation. The Strengthening the Reporting of Observa-
tional Studies in Epidemiology (STROBE) Statement was 
used in the preparation of this section of the manuscript.
Setting and participants
The study was conducted at Great Ormond Street Hospital, 
the regional referral centre for paediatric tumours in North 
London. Two senior neurosurgeons (MT and KA) performed 
all robot-assisted procedures.
All cases were recorded on a prospectively maintained 
database. The database was searched over a 2-year period 
between the 1st December 2015 and the 31st November 
2017 to identify all children with deep-seated lesions that 
underwent robot-assisted stereotactic brain biopsy.
Variables and data sources
Patients had a pre-operative volumetric MRI with con-
trast to identify the tumour and the optimal location for 
biopsy was determined using a multidisciplinary approach. 
Images were then transferred to the Neuromate robot and 
an entry point (EP) and target point (TP) used to define a 
safe surgical trajectory that avoided eloquent tissue, vas-
culature, and transependymal passage. Patients were then 
placed under general anaesthesia, a Leksell frame placed, 
and a CT head performed; this was merged with the pre-
operative MRI scan depending on whether a transcortical 
or transcerebellar approach was used, patients were posi-
tioned supine or prone, respectively, and the robot docked. 
Once registration was performed the robot aligned the tool 
holder along the vector of the planned trajectory; a stereo-
tactic biopsy using a side-cutting Sedan needle was then 
performed in the usual fashion.
Specimens were sent fresh for definitive histopatho-
logical analysis. A biopsy was considered positive if 
specimens resulted in a diagnosis based on histology or 
molecular markers.
A post-operative volumetric CT or MRI was performed 
in selected cases depending on their availability and the 
surgeon’s preference. When accessible, the post-opera-
tive T2-weighted MRI scan and pre-operative plan were 
loaded on the Neuromate robot and compared by a surgeon 
(HJM) to assess the target point localisation error (TPLE) 
(Fig. 1). The TPLE is defined as the Euclidian distance 
between the planned and actual target (the centre of the 
biopsy cavity), and is calculated by determining the square 
root of the sum of the squares of the differences between 
these co-ordinates (x, y, and z) (Fig. 2).
Patients were followed up approximately 2 weeks after 
surgery for wound review and subsequently transferred to 
the care of oncology unless on-going concern. Adverse 
events were defined as any untoward event related to a 
child’s admission that led to an increase in hospital stay, 
caused neurological injury, or led to death. Adverse events 
within 30 days of surgery were graded and recorded pro-
spectively in the following fashion: (1) no increase in 
hospital stay and no neurological injury; (2) increase in 
hospital stay but no neurological injury; (3) neurological 
injury, and (4) death. The strength of this classification 
system is that it records all adverse events whether or not 
they may be related to surgical complications.
Study size and statistical methods
The sample size was determined on a constraint-based 
pragmatic approach as robot-assisted stereotactic brain-
stem biopsies are rare. We considered a minimum of six 
patients sufficient for meaningful analysis.
Data were analysed using with SPSS v 20.0 (IBM, IL, 
USA). The mean and standard deviation were calculated 
for parametric variables, and the median and interquartile 
ranges calculated for non-parametric variables.
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Results
Participants and descriptive data
In all, 11 consecutive children were identified with brain 
tumours located within the brainstem and related struc-
tures that underwent 12 robot-assisted stereotactic brain 
biopsies. The patient demographics are detailed in Table 1. 
The median age was 10 years (range 2–15 years), and the 
male:female ratio was 1:1.2. Brain tumours were most com-
monly located in the pons (9/11) and typically a transcer-
ebellar approach was used (9/11).
Outcome data and main results
In 10/11 cases specimens were diagnostic; in the remaining 
case a further biopsy was successful. The patient patholo-
gies are detailed in Table 1. The most frequent pathology 
was DIPG (7/11).
Seven patients underwent an early post-operative volu-
metric MRI. The calculated median TPLE was 2.7 mm 
(range 0.5–4.2 mm).
There were no surgical complications noted. The median 
length of stay was 2 days (range 2–8 days).
Discussion
Principal findings
We found that robot-assisted stereotactic brainstem biopsy 
in children was both feasible and safe. In our prospec-
tive cohort study, the technique was found to be accurate 
(median TPLE 2.7 mm) and provide a high diagnostic 
Fig. 1  a Pre-operative and b post-operative axial T2-weighted MRI 
scan of demonstrating pontine lesion and right-sided transcerebellar 
approach
P (x,y,z) 
Q (x,y,z) 
x 
y 
z 
Fig. 2  Target point localisation error (TPLE) is defined as the Euclid-
ian distance between the planned and actual target. The planned 
biopsy target is represented by point P, and the actual biopsy target 
by point Q. The arrow is the Euclidian distance between these two 
points
Table 1  Patient demographics and pathology
Case Age Sex Location Approach Pathology
1 15 M Pons Right transcerebellar Inflammatory
2 12 F Pons Right transcerebellar Glioblastoma
3 11 M Midbrain Right transcortical Astrocytoma
4 2 F Pons Right transcerebellar DIPG
5 6 F Midbrain Right transcortical Astrocytoma
6 8 M Pons Right transcerebellar DIPG and 
radiation 
necrosis
7 13 F Pons Left transcerebellar DIPG
8 13 M Pons Right transcerebellar DIPG
9 5 F Pons Left transcerebellar DIPG
10 9 F Pons Left transcerebellar DIPG
11 10 M Pons Right transcerebellar DIPG
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yield (10/11 cases). Moreover, no significant adverse 
events were recorded.
Comparison with other studies
The literature supporting the use of surgical robotics 
within neurosurgery is small but rapidly growing [14]. 
Approximately 300 robot-assisted stereotactic brain biopsy 
procedures have been reported in the literature over the 
last 30 years, but the majority have been reported within 
just the last 5 years [15–22].
Several studies have reported the accuracy of robot-
assisted brain biopsy, albeit in adults. The average target 
accuracy varies in these studies from 0.9 to 4.5 mm, and 
is therefore comparable to our own cohort [10, 11, 23, 24].
In the largest paediatric series to date, De Benedictis 
et al. used the ROSA robot (Medtech, France) and per-
formed 128 robot-assisted surgeries on 115 consecutive 
children, including 26 stereotactic brain biopsy proce-
dures [17]. Although no formal TPLE was calculated, the 
authors reported the technique was accurate with a tissue 
diagnosis in 25/26 cases. One patient had transient wors-
ening of their neurological symptoms, but otherwise no 
complications were noted.
LeFranc et al. used the ROSA robot and performed 
robot-assisted stereotactic biopsy in 100 patients, 
including several children (median age 59 years; range 
7–86 years) [18]. A tissue diagnosis was made in 97/100 
cases. Six patients were found to have a post-operative 
haematoma on imaging, which were associated in transient 
worsening of neurological symptoms in two cases. Four 
further patients also had a transient worsening of their 
neurological symptoms.
Other studies using the ROSA robot have also found 
robot-assisted stereotactic biopsy in children to be feasible 
and safe. Miller et al. reported successful biopsy in six 
patients, Quick-Weller et al. in two patients, Carai et al. in 
seven patients, and Coca et al. in five patients [16, 19–21]; 
a tissue diagnosis was made in 20/20 cases, and transient 
worsening of neurological symptoms in only one patient.
Haegelen et  al. used the Neuromate robot and per-
formed robot-assisted stereotactic brainstem biopsy in 
15 patients, including 5 children [15]. A tissue diagnosis 
was made in 13/15 cases. One case had permanent post-
operative morbidity and two others transient morbidity.
A possible confounder when interpreting the aforemen-
tioned studies, is their use of either the transcortical or 
transcerebellar approach, which is frequently not reported. 
However, in a retrospective study Dellaretti et al. com-
pared these approaches and found no significant difference 
in diagnostic yield or safety [13].
Limitations
The present study has several limitations. Unfortunately, 
the operative time, which has been raised as a concern with 
robot-assisted surgery, was not prospectively recorded. Also, 
early post-operative imaging was only available in selected 
patients limiting the assessment of accuracy.
More generally, the sample size was small as robot-
assisted stereotactic brainstem biopsies are rare. Lastly, the 
uncontrolled prospective cohort study design does not allow 
for rigorous comparison between robotic and standard ste-
reotactic brain biopsy.
Conclusion
Robot-assisted stereotactic brainstem biopsy in children 
appears to be both feasible and safe. With rapid advances 
in robotics, it is likely that future platforms will become 
smaller, more powerful, and less costly, in a way analogous 
to digital computing over the last half century [25]. Eventu-
ally, a tipping point will be reached, allowing for their more 
widespread dissemination. To this end, research databases 
and comparative studies are now warranted to further assess 
the technique in line with the IDEAL model for safe surgical 
innovation.
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